000			01492 a2200409 4500
005			20250513175717.0
264		0	_c19990702
008			199907s 0 0 eng d
022			_a0033-3158
024	7		_a10.1007/s002130050925 _2doi
040			_aNLM _beng _cNLM
100	1		_aHaney, M
245	0	0	_aEffect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. _h[electronic resource]
260			_bPsychopharmacology _cMar 1999
300			_a102-10 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdult
650	0	4	_aCocaine _xadministration & dosage
650	0	4	_aCocaine-Related Disorders _xdrug therapy
650	0	4	_aDopamine Agonists _xadverse effects
650	0	4	_aDopamine Uptake Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aProdrugs _xadverse effects
650	0	4	_aPyridines _xadverse effects
650	0	4	_aSelf Administration
650	0	4	_aTetrahydronaphthalenes _xadverse effects
700	1		_aCollins, E D
700	1		_aWard, A S
700	1		_aFoltin, R W
700	1		_aFischman, M W
773	0		_tPsychopharmacology _gvol. 143 _gno. 1 _gp. 102-10
856	4	0	_uhttps://doi.org/10.1007/s002130050925 _zAvailable from publisher's website
999			_c10186204 _d10186204